TD Waterhouse Canada’s ADMA Biologics ADMA Stock Holding History

TD Waterhouse Canada’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,828	Closed	-$392K	–	1969
2024 Q3	$392K	Buy	+19,828	New	+$308K	﹤0.01%	642

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

TD Waterhouse Canada's ADMA Position: Q4 2024 in Review

TD Waterhouse Canada sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 19,828 shares — an estimated $392K sold.

TD Waterhouse Canada first reported a position in ADMA in Q3 2024 and held it in 1 quarter. The position peaked at $392K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

TD Waterhouse Canada reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
TD Waterhouse Canada sold 19,828 ADMA Biologics shares in Q4 2024, an estimated $392K.
TD Waterhouse Canada first reported a position in ADMA Biologics in Q3 2024 and held it in 1 quarter.
TD Waterhouse Canada's ADMA Biologics position peaked at $392K in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on TD Waterhouse Canada's 13F filing for Q4 2024, filed 13 Feb 2025.